At Elicio, we’re excited about our work, and look forward to sharing information about it with you. Please feel free to get in touch with us.
One Kendall Square
Building 1400 West, Suite 14303
Cambridge, MA 02139
Phone: +1 857 209-0050
For information about our clinical trials, please visit ClinicalTrials.gov.
AMPLIFY-201: First in Human Phase 1/2 Trial of ELI-002 Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors (Protocol Number: ELI-002-001)
Enrolling RAS mutated pancreatic, colorectal, lung, mucinous ovarian, bile duct and gallbladder tumors
For further questions about the trials, contact one of our participating sites listed on ClinicalTrials.gov